---
title: "Actuate Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293072599.md"
description: "Actuate Therapeutics received a Nasdaq notice on July 15, 2026, for failing to meet the $50 million Market Value of Listed Securities requirement. The company has until January 11, 2027, to regain compliance by maintaining the minimum value for 10 consecutive business days. Shares continue trading under the symbol ACTU."
datetime: "2026-07-17T20:33:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293072599.md)
  - [en](https://longbridge.com/en/news/293072599.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293072599.md)
generator: "portal-rs"
---

# Actuate Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard

On July 15, 2026, the company received a Nasdaq notice that its Market Value of Listed Securities was below the $50 million minimum for the Nasdaq Global Market under Listing Rule 5450(b)(2)(A). Actuate has 180 days, through January 11, 2027, to regain compliance by maintaining MVLS of at least $50 million for 10 consecutive business days. The stock continues to trade on the Nasdaq Global Market under the symbol ACTU.

Original SEC Filing: ACTUATE THERAPEUTICS, INC. \[ ACTU \] - 8-K - Jul. 17, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [ACTU.US](https://longbridge.com/en/quote/ACTU.US.md)

## Related News & Research

- [BorgWarner EVP, CAO, Gen Counsel & Sec Sold Shares Worth Over $1.4M](https://longbridge.com/en/news/296948857.md)
- [Ramaco Resources files Form 3 for General Counsel Jonathan Tyler Adkins](https://longbridge.com/en/news/297082090.md)
- [Pixelgen raises $15.5 million in Series B with Industrifonden participation](https://longbridge.com/en/news/297185599.md)
- [MDATA: Raised NOK 650m in IPO, expanded to 650 MW, and targets project monetisation in H2 2026](https://longbridge.com/en/news/296988438.md)
- [If You Invested $1000 In Royalty Pharma Stock 10 Years Ago, You Would Have This Much Today](https://longbridge.com/en/news/296656460.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**